Pilot study of atomoxetine in patients with Parkinson's disease and dopa-unresponsive Freezing of Gait.

Pilot study of atomoxetine in patients with Parkinson's disease and dopa-unresponsive Freezing of Gait. Transl Neurodegener. 2015; 4:24.

View in: PubMed